Eirum Chaudhri

931 citations
3 papers · 531 indexed · 1 hit paper · h-index 3

Eirum Chaudhri

3 papers receiving 514 citations

Hit Papers

Efficacy of boceprevir, an NS3 protease inhibitor, in com...5152010202620152020100200300400500

Peers

Eirum Chaudhri
Comparison fields: 5 of 41
  • Hepatology 509
  • Epidemiology 437
  • Infectious Diseases 113
  • Rheumatology 60
  • Virology 8
Replace D. Hueppe with:
D. Hueppe Germany
Wulf O. Boecher Germany
G. Carosi Italy
Fernando E. Membreno United States
J. Albrecht United States
Fernando Sogari Italy
Monique Chaneac Italy
Valeria Tedeschi United States
F. Vinelli Italy
Shigehiko Sainokami Japan
Eirum Chaudhri relative to D. Hueppe Germany D. Hueppe's profile →
Citations per field
00.5×1.5×
D. Hueppe · 1×
Citations per year

Countries citing papers authored by Eirum Chaudhri

Since Specialization
Citations

This map shows the geographic impact of Eirum Chaudhri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eirum Chaudhri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eirum Chaudhri more than expected).

Fields of papers citing papers by Eirum Chaudhri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eirum Chaudhri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eirum Chaudhri. The network helps show where Eirum Chaudhri may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eirum Chaudhri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eirum Chaudhri Line = papers co-authored together Eirum Chaudhri links everyone, so they are left out of the graph.

All Works

3 of 3 papers shown
#Work
1 201214
2
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trialbreakdown →
2010515
3
Hemoglobin Decline During Lead-in Phase as an Early Predictor of Anemia After the Addition of Boceprevir: A Retrospective Analysis of HCV SPRINT-1
20102

About Eirum Chaudhri

Eirum Chaudhri is a scholar working on Hepatology, Genetics and Hematology, having authored 3 papers that have together received 531 indexed citations. Recurring topics across this work include Hepatitis C virus research (3 papers), Hepatitis B Virus Studies (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Blood groups and transfusion (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Hepatology (509 citations), Epidemiology (437 citations) and Infectious Diseases (113 citations). Eirum Chaudhri has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Lisa D. Pedicone, Paul Y. Kwo, Lorenzo Rossaro, Joseph Galati, Stuart C. Gordon, Janice K. Albrecht, Frank Anderson, John M. Vierling, Mitchell Davis and Natarajan Ravendhran. Their work appears in journals such as Journal of Clinical Gastroenterology and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026